menu
    • menu

    Company profile for Zenas BioPharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and delivery of immune-based therapies for patients in need. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational exce...
    Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and delivery of immune-based therapies for patients in need. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zenas BioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1000 Winter St North Building, Suite 1200 Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zenasbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zenas Biopharma Reveals Q3 2025 Financials & Corporate Update
    Zenas Biopharma Reveals Q3 2025 Financials & Corporate Update

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186095/0/en/Zenas-BioPharma-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Zenas Biopharma To Present At Healthcare Investor Conferences
    Zenas Biopharma To Present At Healthcare Investor Conferences

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185312/0/en/Zenas-BioPharma-to-Present-at-Upcoming-Healthcare-Investor-Conferences.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Zenas Autoimmune Drug Prompts 95% Drop In Lesions In MS Study
    Zenas Autoimmune Drug Prompts 95% Drop In Lesions In MS Study

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174445/0/en/Zenas-BioPharma-Announces-Positive-Results-from-Phase-2-MoonStone-Trial-of-Obexelimab-in-Relapsing-Multiple-Sclerosis.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Zenas Gains MS Hopeful in $2 B Deal with China's InnoCare
    Zenas Gains MS Hopeful in $2 B Deal with China's InnoCare

    09 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/zenas-makes-big-bet-ms-drug-striking-2b-licensing-deal-innocare

    FIERCE PHARMA
    09 Oct 2025
    Share Share
    Royalty bestows Zenas with $300M for Autoimmune Approval Push
    Royalty bestows Zenas with $300M for Autoimmune Approval Push

    02 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/zenas-biopharma-bestowed-300m-royalty-get-autoimmune-asset-across-fda-finish-line

    FIERCE BIOTECH
    02 Sep 2025
    Share Share
    Zenas BioPharma to Present at Healthcare Investor Conferences
    Zenas BioPharma to Present at Healthcare Investor Conferences

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139149/0/en/Zenas-BioPharma-to-Present-at-Upcoming-Healthcare-Investor-Conferences.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search